|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
399 Binney St,Cambridge,Massachusetts,US
|
|
Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Our initial focus is to advance RCT™ product candidates for the treatment cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. Our IND for RTX-240, our first oncology candidate for the treatment of solid tumors, has been cleared by the FDA. Additionally, we plan to file an IND for RTX-321 for the treatment of HPV-positive tumors by year-end. For more information, please visit us at www.rubiustx.com or follow us on Twitter.
|
Rubius Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{first} | [email protected] |
50%
|
The widely used Rubius Therapeutics email format is {first} (e.g. [email protected]) with 50% adoption across the company.
To contact Rubius Therapeutics customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.